These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1808956)
21. Development of drugs for gastrointestinal motor disorders: translating science to clinical need. Sanger GJ; Alpers DH Neurogastroenterol Motil; 2008 Mar; 20(3):177-84. PubMed ID: 18257767 [TBL] [Abstract][Full Text] [Related]
22. [Therapeutic trial of a combination of an insoluble bismuth salt and a Karaya gum in gastrointestinal disorders]. Héraud M; Paris JC Lille Med; 1969; ():677-9. PubMed ID: 5404535 [No Abstract] [Full Text] [Related]
23. [Clinical evaluation of a new drug for gastrointestinal disorders]. Jefferson NC Rev Esp Enferm Apar Dig; 1968 May; 27(5):796-801. PubMed ID: 5739534 [No Abstract] [Full Text] [Related]
24. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? Cutts TF; Luo J; Starkebaum W; Rashed H; Abell TL Neurogastroenterol Motil; 2005 Feb; 17(1):35-43. PubMed ID: 15670262 [TBL] [Abstract][Full Text] [Related]
25. [Historical aspects of drug therapy of gastrointestinal diseases]. Kupferschmidt H Ther Umsch; 1997 Nov; 54(11):607-10. PubMed ID: 9454360 [No Abstract] [Full Text] [Related]
26. An evaluation of the effectiveness of simethicone in acute upper gastrointesinal distress. Bernstein JE; Schwartz SR Curr Ther Res Clin Exp; 1974 Jun; 16(6):617-20. PubMed ID: 4211142 [No Abstract] [Full Text] [Related]
27. [An original therapeutic approach in digestive pathology]. Hecht Y Therapeutique; 1972 Dec; 48(10):701-4. PubMed ID: 4661293 [No Abstract] [Full Text] [Related]
28. [Clinical evaluation of a new preparation in upper digestive processes]. Maldonado Eloy-García J; Escalante Llamas A; Ariza Moscoso A; Moreno López JM; Pérez Olivares J Rev Esp Enferm Apar Dig; 1974 Apr; 43(1):89-108. PubMed ID: 4840627 [No Abstract] [Full Text] [Related]
30. [Trial of Ultra-Zym in digestive diseases]. Dorf G Med Chir Dig; 1977; 6(6):389-92. PubMed ID: 926887 [No Abstract] [Full Text] [Related]
31. Pharmacogenomics in gastrointestinal disorders. Camilleri M; Saito YA Methods Mol Biol; 2008; 448():395-412. PubMed ID: 18370239 [TBL] [Abstract][Full Text] [Related]
32. [Interactions of drugs used in gastroenterology]. Milonova NP; Dotsenko NIa; Orlovskiĭ VF Klin Med (Mosk); 1985 Aug; 63(8):15-8. PubMed ID: 4079319 [No Abstract] [Full Text] [Related]
33. Use of cisapride. Mathew A Indian Pediatr; 2000 Dec; 37(12):1402-4. PubMed ID: 11119361 [No Abstract] [Full Text] [Related]
34. [Cisapride and other prokinetic agents in the treatment of gastroenterological diseases]. Ryss ES; Fishzon-Ryss IuI Ter Arkh; 1995; 67(2):58-61. PubMed ID: 7725263 [No Abstract] [Full Text] [Related]
35. Drug interactions in gastroenterology: mechanisms, consequences, and how to avoid. Egan LJ Clin Gastroenterol Hepatol; 2004 Sep; 2(9):725-30. PubMed ID: 15354272 [TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal problems and HIV. The effect on treatment success. Monroe A Posit Aware; 2005; Spec No():9-15. PubMed ID: 16335473 [No Abstract] [Full Text] [Related]
37. [Value of Mexase in digestive pathology]. Félix MH J Med Lyon; 1970 Mar; 51(182):663-78. PubMed ID: 4248934 [No Abstract] [Full Text] [Related]
38. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine. Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849 [TBL] [Abstract][Full Text] [Related]
39. Proton pump inhibitor therapy and Helicobacter pylori infection: a complicated relationship. McColl K Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):185-6. PubMed ID: 16930290 [No Abstract] [Full Text] [Related]